DNDN - Dendreon Corp - Page 73

Yes, just adds to the laundry list of examples as to why I never use stop losses. Another example would be POZN's action today.

Definately get a rollercoaster ride with some of these Biotechs. But such good money can be made

sold this one today, hoping for some selling so I can get some cheaper shares

any one think this still has a way to go down? any one got puts on it?
I should have put this like I thought a couple days ago instead of what I did

grabbed some shares today in the low 40s

DNDN june/july 45 calls are looking good around this level... a little bit of intra day consolidating happing.

One options trader is betting that DNDN will not only hold firmly above growing short-term support at the 42 level, but also rebound sharply from this level before May options expire at the end of the week. Specifically, a block of 271 May 44 contracts traded at the bid price of $0.42 on the International Securities Exchange (ISE) at about 11:48 a.m. Eastern time. This block was marked "spread." The other half of this trade crossed on the May 42 call, where a block of 271 contracts traded at the same time on the same exchange for the ask price of $1.07. Given this data, it would appear that we are looking at a vertical call spread, more commonly known as a debit spread, on Dendreon Corp. This options strategy is also known as a long call spread, or a bull call spread.

+1.45 AH Strong support on the 50ma.


picked up some june 50 calls

SEATTLE and CHICAGO, May 20 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced the upcoming presentation of data from integrated analyses of three Phase 3 PROVENGE® (sipuleucel-T) clinical trials of an autologous cellular immunotherapy in advanced prostate cancer, to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago on Monday, June 7 at 8:00 a.m. CT.
"With the recent FDA approval of PROVENGE for asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer, patients now have a new treatment option available that prolongs survival," said Daniel P. Petrylak, M.D., program director of the Genitourinary Oncology Section in the Division of Hematology/Oncology at Columbia University. *"Cancer immunotherapy represents an entirely new era in medicine and patient care."

Simple 7% gain from playing the support around $40 today ....gogogoog

holding DNDN still?

If we can close above 43.90.. I like to see this fly to 47-48

This stock is being absolutely POUNDED today. Screw that, I'm loading up big. They have an approved CANCER VACCINE, for crying out loud.

Buying on weakness, putting in a bid for 5000 shares.

agree, just wish i could buy 5k

I went to do some work. Came back and saw this stock had absolutely PLUMMETED on the stock ticker.

Thankfully I'm not in on it right now, but...what the heck happened? I'm now looking at an entry point.

After Hours: 26.61 -5.72/-17.10% Vol. 3.02 Mil

crazy....someone knows something...now cough it up.

it's our new govt healthcare scam at work:

BRIEF-US Medicare to decide coverage for prostate cancer vaccines
http://www.cnbc.com/id/38024694

I fail to see how that drives a stock down 28%. I mean, it just says they're going to evaluate the drug. Unless investors are just scared that they don't think the vaccine actually works.

Cover me, Wilson; I'm goin' in. This thing HAS to bounce back off non-news like that.

Check it tommorow, might sell puts

Watch the pretty stock ticker at the bottom of the financial TV stations. See all those alternating 1K, 1.5K orders (Well, you probably don't yet, since those tickers operate on a lag)? That's your dear friend Quin buying 30,000 shares in scripted bursts.